Skip to main content

Table 2 Multivariate analysis of risk factors of chemo-resistance among endometriosis related ovarian cancer patients

From: Clinical analysis of chemo-resistance risk factors in endometriosis associated ovarian cancer

 

B

S.E.

P

OR(95%CI)

Age

.337

.395

.393

1.4(0.65~ 3.04)

Bloating

−.057

.401

.886

0.94(0.43~ 2.07)

Emaciation

1.447

.791

.067

4.25(0.9~ 20.02)

Ca125 in normal range

.728

.797

.361

2.07(0.43~ 9.87)

EM

−.016

.573

.978

0.98(0.32~ 3.03)

FIGO stagea

1.422

.497

.004*

4.15(1.57~ 10.97)

LN metastasis

.980

.477

.040*

2.66(1.05~ 6.78)

LN dissection

1.059

.440

.016*

2.88(1.22~ 6.82)

Residual disease

.396

.405

.328*

1.49(0.67~ 3.29)

Breast cancer

1.851

.918

.044*

6.37(1.05~ 38.49)

Constant

−5.388

1.018

.000

 
  1. *The difference reached statistical significance. P values were cultivated by Cox regression analysis. The overall test of the above model showed the model was significance, p < 0.0001
  2. aAccording to the classification system of FIGO staging (2013 version)
  3. Abbreviation: Ca125 cancer antigen 125, EM endometriosis, LN lymph node